Effect of Continuous Glucose Monitoring on Hypoglycemia in Adults With Pancreatogenic Diabetes

Inclusion Criteria: * Signed informed consent before any study specific procedures * Able to read and understand Danish * Male or female age ≥ 18 ≤ 85 years * A definitive diagnosis of chronic pancreatitis based on the M-ANNHEIM criteria * A diagnosis of insulin treated pancreatogenic diabetes based on the World Health Organization criteria for diabetes (HbA1c ≥6.5 % (48 mmol/mol) and/or fasting plasma glucose ≥126 mg/dl (7.0 mmol/l)) \>3 months after diagnosis of pancreatitis Exclusion Criteria: * Known or suspected abdominal cancer (incl. intestine, pancreas, and the hepato-biliary system) * Severe pre-existing comorbidities (assessed by investigator upon inclusion) * Attack of acute on chronic pancreatitis requiring admission within four weeks prior to inclusion * Use of glucocorticoid medications within four weeks prior to inclusion, with the exception of inhaled glucocorticoids in the treatment of chronic pulmonary diseases. * Presence of autoimmune antibodies suggestive of type 1 diabetes * Prior pancreatic surgery (including total pancreatectomy, pancreaticoduodenectomy, distal pancreatectomy, pancreaticojejunostomy, enucleation, or Frey procedure) * Prior gastric surgery or vagotomy * Autoimmune pancreatitis